| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2023―Okt―04 |
Preventing atrial fibrillation in COVID-19: exploring the role of interleukin-6 receptor antagonists |
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan |
| 2 |
[GO] |
2023―Sep―27 |
In response to: preventing atrial fibrillation in COVID-19: exploring the role of interleukin-6 receptor antagonists |
Praveen Gupta, Anunay Gupta, Sandeep Bansal, Sumita Saluja, Kapil Gupta |
| 3 |
[GO] |
2023―Jul―06 |
Contemporary outcomes of long-term anticoagulation in COVID-19 patients: a regression matched sensitivity analysis of the national inpatient sample |
Amro Taha, Irisha Badu, Harigopal Sandhyavenu, Varun Victor, Sanchit Duhan, Lalitsiri Atti, et al. (+9) Hasham Masood Qureshi, Thatiana Schulze Goni, Bijeta Keisham, Vasantha Sandhya Venu, Harshith Thyagaturu, Karthik Gonuguntla, Waqas Ullah, Himanshu Deshwal, Sudarshan Balla |
| 4 |
[GO] |
2023―Mai―19 |
Prevalence of arrhythmia in COVID-19 patients with mild/moderate and severe illness: a prospective cohort study |
Praveen Gupta, Sandeep Bansal, Anunay Gupta, Kapil Gupta, Sumita Saluja, Sudheesh Kumar Kattumannil |
| 5 |
[GO] |
2023―Apr―11 |
Cardiovascular outcomes of type 2 myocardial infarction among COVID-19 patients: a propensity matched national study |
Yasar Sattar, Amro Taha, Neel Patel, Varun Victor, Anoop Titus, Shazia Aziz, et al. (+7) Karthik Gonuguntla, Harshith Thyagaturu, Lalitsiri Atti, Tarec Micho, Talal Almas, M. Chadi Alraies, Sudarshan Balla |
| 6 |
[GO] |
2023―Mrz―01 |
COVID-19 and its long-term impact on the cardiovascular system |
Bejoy Philip, Prerona Mukherjee, Yuti Khare, Pranav Ramesh, Sara Zaidi, Haytham Sabry, Amer Harky |
| 7 |
[GO] |
2023―Feb―23 |
Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in hospitalized patients with COVID-19: an updated systematic review and meta-analysis of randomized clinical trials |
Joseph Alexander Paguio, Bruce Adrian Casipit, Tara A John, Aniruddh Balu, Kevin Bryan Lo |
| 8 |
[GO] |
2022―Dez―19 |
How has COVID-19 impacted the care of patients with acute coronary syndromes? |
Arturo Cesaro, Gianantonio De Michele, Felice Gragnano, Paolo Calabrò |
| 9 |
[GO] |
2022―Okt―03 |
Managing Covid-19 in patients with heart failure: current status and future prospects |
Hawani Sasmaya Prameswari, Iwan Cahyo Santosa Putra, Wilson Matthew Raffaello, Michael Nathaniel, Adrian Sebastian Suhendro, Achmad Fitrah Khalid, Raymond Pranata |
| 10 |
[GO] |
2022―Okt―03 |
High degree atrioventricular block and COVID-19 infection: a two player match? |
Raffaella Mormile |
| 11 |
[GO] |
2022―Jun―21 |
Stress and cardiovascular risk burden after the pandemic: current status and future prospects |
Anna Vittoria Mattioli, Francesca Coppi, Milena Nasi, Sabina Gallina |
| 12 |
[GO] |
2022―Mai―24 |
The role of statin therapy in COVID-19 |
Lori B. Daniels, Kris Kumar |
| 13 |
[GO] |
2022―Apr―13 |
Myocarditis following COVID-19 vaccination: incidence, mechanisms, and clinical considerations |
John R. Power, Lucas K. Keyt, Eric D. Adler |
| 14 |
[GO] |
2022―Feb―18 |
Myocarditis and pericarditis following mRNA COVID-19 vaccination in younger patients: is there a shared thread? |
Raffaella Mormile |
| 15 |
[GO] |
2021―Okt―27 |
Cardiac arrhythmias associated with COVID-19 infection: state of the art review |
Marwan Muhammad, Mustafa Emin, Ayat Bhutta, Essa H. Gul, Elijah Voorhees, Muhammad R. Afzal |
| 16 |
[GO] |
2021―Okt―10 |
Cardiopulmonary exercise testing as a vital sign in patients recovering from COVID-19 |
Ross Arena, Mark A Faghy |
| 17 |
[GO] |
2021―Aug―19 |
In-hospital outcomes of COVID-19 infection in patients with underlying cardiovascular disease |
Khalid Changal, Sean Mack, Spiro Verija, David Paternite, Rehana Bashir, Mitra Patel, et al. (+5) Muhammad Ali, Salik Nazir, Tanveer Mir, Mujeeb Sheikh, P. Kasi Ramanathan |
| 18 |
[GO] |
2021―Jul―13 |
COVID-19 myocarditis and lasting heart damage: is deregulation of the Beclin1-Survivin axis the critical step of pathogenesis? |
Raffaella Mormile |
| 19 |
[GO] |
2020―Dez―10 |
Response to the letter to the editor entitled “Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic” |
Leonardo Grabinski Bottino, Flávio Danni Fuchs |
| 20 |
[GO] |
2020―Okt―29 |
COVID-19 myocarditis and prospective heart failure burden |
Anastasia Shchedrygina, Eike Nagel, Valentina O. Puntmann, Silvia Valbuena-Lopez |
| 21 |
[GO] |
2020―Okt―28 |
Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic |
Chia Siang Kow, Syed Shahzad Hasan |
| 22 |
[GO] |
2020―Sep―18 |
Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers and Outcomes in patients with COVID-19: A Systematic Review and Meta-Analysis |
Kevin Bryan Lo, Ruchika Bhargav, Grace Salacup, Jerald Pelayo, Jeri Albano, Peter A. McCullough, Janani Rangaswami |
| 23 |
[GO] |
2020―Aug―26 |
COVID-19 and Renin-Angiotensin System Modulators: What Do We Know So Far? |
Angel de la Cruz, Shoaib Ashraf, Timothy J. Vittorio, Jonathan N. Bella |
| 24 |
[GO] |
2020―Jul―23 |
Pharmacotherapeutic considerations for the management of cardiovascular diseases among hospitalized COVID-19 patients |
Chia Siang Kow, Kaeshaelya Thiruchelvam, Syed Shahzad Hasan |
| 25 |
[GO] |
2020―Jul―16 |
Epidemiology, prognosis and clinical manifestation of cardiovascular disease in COVID-19 |
Valentina Capone, Vittoria Cuomo, Roberta Esposito, Mario Enrico Canonico, Federica Ilardi, Maria Prastaro, et al. (+2) Giovanni Esposito, Ciro Santoro |
